Business
Fresenius Kabi’s Adaptive Nomogram used on Aurora Xi Plasmapheresis System Now Operating Nationwide at BioLife Plasma Centers
LAKE ZURICH, Ill., November 12, 2025--Fresenius Kabi, part of the global healthcare company Fresenius, and a leading provider of essential medicines and medical technologies, announced today the successful completion of the U.S. rollout of the Adaptive Nomogram technology used on its Aurora Xi Plasmapheresis System across BioLife Plasma Services’ network of plasma donation centers. The implementation, which began in March 2025 in a phased approach, has been completed ahead of schedule, marking a
About this update from Fresenius Se & Co. Kgaa
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":2000,"height":593,"url":"https://media.zenfs.com/en/business-wire.com/e1cda0b391ff98002c05abc1a8df55b9"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/E5eORbaU3A1mIyqaGBLjfQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTI4NTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/e1cda0b391ff98002c05abc1a8df55b9","width":960,"height":285},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/6p3NsQmoZFoFsTjLmU.1_Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD03MTI7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/e1cda0b391ff98002c05abc1a8df55b9","width":1200,"height":356}},"lazy":false},{"type":"text","content":"LAKE ZURICH, Ill., November 12, 2025--(BUSINESS WIRE)--Fresenius Kabi, part of the global healthcare company Fresenius, and a leading provider of essential medicines and medical technologies, announced today the successful completion of the U.S. rollout of the Adaptive Nomogram technology used on its Aurora Xi Plasmapheresis System across BioLife Plasma Services’ network of plasma donation centers. The implementation, which began in March 2025 in a phased approach, has been completed ahead of schedule, marking a significant milestone in helping plasma centers advance plasma collection efficiency and donation personalization.","length":632,"tagName":"p"},{"type":"text","content":"The Adaptive Nomogram technology, used with Fresenius Kabi’s Aurora Xi Plasmapheresis System, optimizes plasma collection by tailoring donation volumes based on each donor’s individual body attributes. This data-driven approach enables more personalized and efficient plasma collection, supporting both donor safety and the sustainability of the plasma supply.","length":360,"tagName":"p"},{"type":"text","content":""We are proud to see our Adaptive Nomogram technology fully deployed at BioLife Plasma Services’ donation centers and delivering measurable impact while meeting BioLife’s expectations," said Dr. Christian Hauer, President, MedTech at Fresenius Kabi. "This innovation brings a new level of personalization to plasma donations, helping our customers enhance efficiency and strengthen the sustainability of the plasma supply that is essential for lifesaving therapies."","length":486,"tagName":"p"},{"type...